Original Study
“Somebody Like Me”: Understanding COVID-19 Vaccine Hesitancy among Staff in Skilled Nursing Facilities

https://doi.org/10.1016/j.jamda.2021.03.012Get rights and content

Abstract

Objective

The vaccination of skilled nursing facility (SNF) staff is a critical component in the battle against COVID-19. Together, residents and staff constitute the single most vulnerable population in the pandemic. The health of these workers is completely entangled with the health of those they care for. Vaccination of SNF staff is key to increasing uptake of the vaccine, reducing health disparities, and reopening SNFs to visitors. Yet, as the vaccine rollout begins, some SNF staff are declining to be vaccinated. The purpose of this article is to describe reasons for COVID-19 vaccine hesitancy reported by staff of skilled nursing facilities and understand factors that could potentially reduce hesitancy.

Design

Five virtual focus groups were conducted with staff of SNFs as part of a larger project to improve vaccine uptake.

Setting and Participants

Focus groups with 58 staff members were conducted virtually using Zoom.

Measures

Focus groups sought to elicit concerns, perspectives, and experiences related to COVID-19 testing and vaccination.

Results

Our findings indicate that some SNF staff are hesitant to receive the COVID-19 vaccine. Reasons for this hesitancy include beliefs that the vaccine has been developed too fast and without sufficient testing; personal fears about pre-existing medical conditions, and more general distrust of the government.

Conclusions and Implications

SNF staff indicate that seeing people like themselves receive the vaccination is more important than seeing public figures. We discuss the vaccination effort as a social enterprise and the need to develop long-term care provider-academic-community partnerships in response to COVID-19 and in expectation of future pandemics.

Keywords

COVID-19
vaccination
skilled nursing facilities

Cited by (0)

This work was supported through a supplemental award by the National Institute on Aging (NIA) of the National Institutes of Health under Award Number (3U54AG063546-02S2) to the NIA Imbedded Pragmatic Alzheimer's Disease and AD-Related Dementias Clinical Trials Collaboratory (NIA IMPACT Collaboratory, U54AG063546) as part of the RADx Underserved Populations (RADx-UP) program that supports 32 institutions across the United States to focus on populations disproportionately affected by the pandemic. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The authors declare no conflicts of interest.

View Abstract